Found: 4
Select item for more details and to access through your institution.
Cabozantinib and Panitumumab for RAS Wild‐Type Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. 465, doi. 10.1002/onco.13678
- By:
- Publication type:
- Article
A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2149040, doi. 10.1001/jamanetworkopen.2021.49040
- By:
- Publication type:
- Article
A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article